Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus
Another week of escalating tariff talks led to a slump across major U.S. stock market indices for the five-day trading period. The S&P 500 dropped nearly 3% for the week, with losses in three of the ...
Merck plans to launch US subcutaneous version of Keytruda on October 1
Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
Analysis-Trump Turbulence Stalls Large Pharma and Biotech Deals, Bankers Say
NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
Bangladesh reports first bird flu outbreak on farm since 2018, WOAH says
Bangladesh reported a first outbreak of highly pathogenic bird flu on a farm since 2018, the World Organisation for Animal ...
Merck buys rights to heart disease drug in latest China deal
Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...